Article

Safety and Efficacy of the FAKHRAVAC Compared with BBIBP-Corv2 Against SARS-CoV-2 in Adults: A Non-Inferiority Multi-Center Trial

2022-10-17

Abstract excerpt

Introduction and background We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial.<br><br>Method We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial assessing the safety and efficacy of Fakhravac and BBIBP-Corv2 vaccines. We started with two randomized double-blind arms and added two non-randomized open-label arms (based on participant preference) because of slo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 978204d9-cce9-5034-8b81-d3be8a88f096
DOI: 10.2139/ssrn.4249796

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety and Efficacy of the FAKHRAVAC Compared with BBIBP-Corv2 Against SARS-CoV-2 in Adults: A Non-Inferiority Multi-Center TrialDOI 10.2139/ssrn.4249796Read

An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccineSemantic proximity Read

Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical TrialSemantic proximity Read

Safety and Immunogenicity of an Inactivated Whole Virion SARS-CoV-2 Vaccine, TURKOVAC, in Healthy Adults: Interim Results from Randomised, Double-Blind, Placebo-Controlled Phase 1 and 2 TrialsSemantic proximity Read

Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trialSemantic proximity Read

Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionSemantic proximity Read

Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III TrialSemantic proximity Read

A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial for Adult Evaluation of the Efficacy and Safety of a Sars-Cov-2 Recombinant Spike Rbd Protein Vaccine (Abdala-3 Study)Semantic proximity Read

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialSemantic proximity Read

Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and ReportsSemantic proximity Read

Safety and efficacy of two immunization schedules with an inactivated SARS-CoV-2 vaccine in adults. A randomized non-inferiority clinical trialSemantic proximity Read

REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 OutpatientsSemantic proximity Read

Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) In Adults in a Phase 2/3, Observer-Blind, Randomised, Controlled StudySemantic proximity Read